test

A Phase II, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients with Stage IIIB or IV Non-Small Cell Lung Cancer

Conditions

Non Small Cell Lung Cancer

What is the purpose of this trial?


Participation Guidelines

Age:
18 Years and older
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Infinity Pharmaceuticals
Dates:
June 2011
Last Updated:
Study HIC#:
1104008281